NF-κB activation in MM cells has been inferred from transcriptomic data [9], immunohistochemistry (IHC) imaging on BM samples [10, 11] or in vitro by biochemical approaches on isolated cell populations, in experimental timeframes of days [11, 12]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.